Document is current
Any future updates will be listed below
-
Authors
Mickeviciene, D.
Baltusiene, A. http://orcid.org/0000-0003-3953-597X
Afanasjeva, B.
Afanasjevas, D.
Gleizniene, R.
Rastenyte, D.
Berger, JR.
- License Information
-
More Information
Article History
Received: 13 October 2021
Accepted: 14 August 2022
First Online: 19 August 2022
Declarations
:
: Not applicable.
: The patient provided her written consent for publishing this case report.
: Dr. Joseph R. Berger has received grant support from Biogen and Genentech/Roche. He has received honoraria as a consultant for Amgen, Biogen, Bristol Myers Squibb/Celgene, Dr. Reddy, EMD Serono, Encycle, Excision-Bio, Genentech/Roche, Genzyme, MAPI, Merck, Millennium/Takeda, Morphic, and Shire.D. Mickeviciene reports grants and consulting fees from Merck/EMD Serono, Novartis, Roche, and Sanofi Genzyme, outside the submitted work.A. Baltusiene has no conflict of interest.B. Afanasjeva has no conflict of interest.D. Afanasjevas has no conflict of interest.Prof. R. Gleizniene has no conflict of interest.Prof. D. Rastenyte has no conflict of interest.
